While low GS levels can be beneficial for GBM patients as above-mentioned [156], an experimental study showed that silencing GS potentiated rat C6 glioma cell motility [158], whereas in another study, GS silencing decreased GBM cell line proliferation and colony formation both in the presence and absence of glutamine [159]. This evidence concerns the gene GLUL and central nervous system cancer.